Pulmonary Artery Pressure Reduction With ENTresto (Sacubitril/Valsartan)

NCT02788656 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Inadequate Recruitment

Conditions

Congestive Heart Failure

Interventions

DEVICE: Implantable Hemodynamic Monitor
DRUG: Angiotensin-Converting Enzyme Inhibitor
DRUG: Angiotensin II Type 1 Receptor Blocker
DRUG: sacubitril/valsartan

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]